Carderock Capital Management’s Johnson & Johnson JNJ Stock Holding History

Carderock Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,325	Closed	-$324K	–	75
2026 Q1	$324K	Hold	1,325	–	–	0.08%	59
2025 Q4	$274K	Hold	1,325	–	–	0.07%	59
2025 Q3	$246K	Hold	1,325	–	–	0.06%	65
2025 Q2	$202K	Hold	1,325	–	–	0.05%	73
2025 Q1	$220K	Sell	1,325 -125	-9%	-$19.6K	0.06%	68
2024 Q4	$210K	Hold	1,450	–	–	0.05%	71
2024 Q3	$235K	Sell	1,450 -50	-3%	-$7.97K	0.06%	68
2024 Q2	$219K	Sell	1,500 -100	-6%	-$14.9K	0.06%	66
2024 Q1	$253K	Hold	1,600	–	–	0.07%	60
2023 Q4	$251K	Buy	1,600 +17	+1%	+$2.61K	0.07%	58
2023 Q3	$247K	Buy	+1,583	New	+$261K	0.08%	54
2023 Q2	–	Sell	-1,350	Closed	-$209K	–	86
2023 Q1	$209K	Sell	1,350 -1,322	-49%	-$213K	0.07%	60
2022 Q4	$472K	Buy	2,672 +545	+26%	+$94.1K	0.2%	54
2022 Q3	$347K	Buy	2,127 +127	+6%	+$21.5K	0.18%	56
2022 Q2	$355K	Sell	2,000 -119	-6%	-$21.2K	0.15%	59
2022 Q1	$376K	Sell	2,119 -220	-9%	-$37.4K	0.12%	61
2021 Q4	$400K	Hold	2,339	–	–	0.1%	62
2021 Q3	$378K	Sell	2,339 -584	-20%	-$99.6K	0.11%	65
2021 Q2	$482K	Sell	2,923 -475	-14%	-$78.6K	0.13%	69
2021 Q1	$558K	Buy	3,398 +148	+5%	+$23.9K	0.17%	63
2020 Q4	$511K	Hold	3,250	–	–	0.15%	63
2020 Q3	$484K	Sell	3,250 -1,064	-25%	-$157K	0.16%	59
2020 Q2	$607K	Sell	4,314 -625	-13%	-$91.1K	0.22%	57
2020 Q1	$648K	Sell	4,939 -100	-2%	-$14.2K	0.3%	54
2019 Q4	$735K	Sell	5,039 -50	-1%	-$6.78K	0.25%	60
2019 Q3	$658K	Buy	5,089 +50	+1%	+$6.59K	0.24%	60
2019 Q2	$702K	Sell	5,039 -50	-1%	-$6.92K	0.27%	59
2019 Q1	$711K	Sell	5,089 -11	-0.2%	-$1.47K	0.29%	60
2018 Q4	$658K	Sell	5,100 -167	-3%	-$23.3K	0.34%	56
2018 Q3	$728K	Hold	5,267	–	–	0.29%	64
2018 Q2	$639K	Sell	5,267 -1,118	-18%	-$139K	0.28%	65
2018 Q1	$818K	Sell	6,385 -100	-2%	-$13.5K	0.36%	58
2017 Q4	$906K	Sell	6,485 -701	-10%	-$97.6K	0.4%	59
2017 Q3	$934K	Hold	7,186	–	–	0.42%	57
2017 Q2	$951K	Buy	7,186 +57	+0.8%	+$7.27K	0.43%	59
2017 Q1	$888K	Sell	7,129 -1,522	-18%	-$182K	0.41%	59
2016 Q4	$997K	Buy	8,651 +75	+0.9%	+$8.66K	0.5%	55
2016 Q3	$1.01M	Sell	8,576 -50	-0.6%	-$6.07K	0.51%	53
2016 Q2	$1.05M	Sell	8,626 -550	-6%	-$62.5K	0.55%	53
2016 Q1	$993K	Sell	9,176 -75	-0.8%	-$7.76K	0.51%	54
2015 Q4	$950K	Sell	9,251 -100	-1%	-$10.1K	0.49%	56
2015 Q3	$873K	Hold	9,351	–	–	0.49%	54
2015 Q2	$911K	Sell	9,351 -75	-0.8%	-$7.51K	0.46%	57
2015 Q1	$948K	Sell	9,426 -50	-0.5%	-$5.08K	0.46%	55
2014 Q4	$991K	Hold	9,476	–	–	0.49%	58
2014 Q3	$1.01M	Sell	9,476 -1,380	-13%	-$143K	0.52%	59
2014 Q2	$1.14M	Sell	10,856 -100	-0.9%	-$10.1K	0.59%	57
2014 Q1	$1.08M	Buy	10,956 +325	+3%	+$30.1K	0.55%	61
2013 Q4	$974K	Buy	10,631 +375	+4%	+$34.6K	0.51%	61
2013 Q3	$889K	Sell	10,256 -1,269	-11%	-$114K	0.52%	60
2013 Q2	$990K	Buy	+11,525	New	+$978K	0.58%	57

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Carderock Capital Management's JNJ Position: Q2 2026 in Review

Carderock Capital Management sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 1,325 shares — an estimated $324K sold.

Carderock Capital Management first reported a position in JNJ in Q2 2013 and held it in 51 quarters. The position peaked at $1.14M in Q2 2014. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Carderock Capital Management reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
Carderock Capital Management sold 1,325 Johnson & Johnson shares in Q2 2026, an estimated $324K.
Carderock Capital Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 51 quarters.
Carderock Capital Management's Johnson & Johnson position peaked at $1.14M in Q2 2014.
2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Carderock Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.